Abstract
PS-15, a new dihydrofolate reductase inhibitor, and its cyclic metabolite were evaluated for in vitro activity against 31 clinical Mycobacterium avium complex isolates. Broth dilution MICs of PS-15 ranged from 16 to 64 micrograms/ml. The cyclic metabolite was three to five times more active than the parent compound. Further evaluation of these compounds in an M. avium-infected murine test system will be of interest.
Full Text
The Full Text of this article is available as a PDF (201.2 KB).
Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- Canfield C. J., Milhous W. K., Ager A. L., Rossan R. N., Sweeney T. R., Lewis N. J., Jacobus D. P. PS-15: a potent, orally active antimalarial from a new class of folic acid antagonists. Am J Trop Med Hyg. 1993 Jul;49(1):121–126. doi: 10.4269/ajtmh.1993.49.121. [DOI] [PubMed] [Google Scholar]
- Edstein M. D., Corcoran K. D., Shanks G. D., Ngampochjana M., Hansukjariya P., Sattabongkot J., Webster H. K., Rieckmann K. H. Evaluation of WR250417 (a proguanil analog) for causal prophylactic activity in the Plasmodium cynomolgi-Macaca mulatta model. Am J Trop Med Hyg. 1994 Feb;50(2):181–186. doi: 10.4269/ajtmh.1994.50.181. [DOI] [PubMed] [Google Scholar]
- Gallant J. E., Moore R. D., Chaisson R. E. Prophylaxis for opportunistic infections in patients with HIV infection. Ann Intern Med. 1994 Jun 1;120(11):932–944. doi: 10.7326/0003-4819-120-11-199406010-00006. [DOI] [PubMed] [Google Scholar]
- Hughes W. T., Jacobus D. P., Canfield C., Killmar J. Anti-Pneumocystis carinii activity of PS-15, a new biguanide folate antagonist. Antimicrob Agents Chemother. 1993 Jul;37(7):1417–1419. doi: 10.1128/aac.37.7.1417. [DOI] [PMC free article] [PubMed] [Google Scholar]